PubMed:26658904
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-109 | Sentence | denotes | Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis. |
| T2 | 110-121 | Sentence | denotes | OBJECTIVES: |
| T3 | 122-276 | Sentence | denotes | Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by persistent synovitis, ultimately leading to cartilage and bone degeneration. |
| T4 | 277-369 | Sentence | denotes | Natural Killer cells and CD28 null T-cells are suspected as role players in RA pathogenesis. |
| T5 | 370-531 | Sentence | denotes | These cells are similar in feature and function, as they both exert their cytotoxic effect via Killer Cell Immunoglobulin- Like Receptors (KIR) on their surface. |
| T6 | 532-635 | Sentence | denotes | KIR genes have either an inhibitory or activating effect depending on their intracytoplasmic structure. |
| T7 | 636-776 | Sentence | denotes | Herein we genotyped 16 KIR genes, 3 pseudo genes and 6 HLA class І genes as their corresponding ligands in RA patients and control subjects. |
| T8 | 777-785 | Sentence | denotes | METHODS: |
| T9 | 786-941 | Sentence | denotes | In this case-control study, KIR and HLA genes were genotyped in 400 RA patients and 372 matched healthy controls using sequence-specific primers (SSP-PCR). |
| T10 | 942-1022 | Sentence | denotes | Differences in the frequency of genes and haplotypes were determined by χ² test. |
| T11 | 1023-1122 | Sentence | denotes | RESULTS: KIR2DL2, 2DL5a, 2DL5b and activating KIR: KIR2DS5 and 3DS1 were all protective against RA. |
| T12 | 1123-1266 | Sentence | denotes | KIR2DL5 removal from a full Inhibitory KIR haplotype converted the mild protection (OR = 0.56) to a powerful predisposition to RA (OR = 16.47). |
| T13 | 1267-1291 | Sentence | denotes | Inhibitory haplotype No. |
| T14 | 1292-1398 | Sentence | denotes | 7 comprising KIR2DL5 in the absence of KIR2DL1 and KIR2DL3 confers a 14-fold protective effect against RA. |
| T15 | 1399-1410 | Sentence | denotes | CONCLUSION: |
| T16 | 1411-1464 | Sentence | denotes | Individuals carrying the inhibitory KIR haplotype No. |
| T17 | 1465-1512 | Sentence | denotes | 6 have a high potential risk for developing RA. |
| T1 | 0-109 | Sentence | denotes | Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis. |
| T2 | 110-121 | Sentence | denotes | OBJECTIVES: |
| T3 | 122-276 | Sentence | denotes | Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by persistent synovitis, ultimately leading to cartilage and bone degeneration. |
| T4 | 277-369 | Sentence | denotes | Natural Killer cells and CD28 null T-cells are suspected as role players in RA pathogenesis. |
| T5 | 370-531 | Sentence | denotes | These cells are similar in feature and function, as they both exert their cytotoxic effect via Killer Cell Immunoglobulin- Like Receptors (KIR) on their surface. |
| T6 | 532-635 | Sentence | denotes | KIR genes have either an inhibitory or activating effect depending on their intracytoplasmic structure. |
| T7 | 636-776 | Sentence | denotes | Herein we genotyped 16 KIR genes, 3 pseudo genes and 6 HLA class І genes as their corresponding ligands in RA patients and control subjects. |
| T8 | 777-785 | Sentence | denotes | METHODS: |
| T9 | 786-941 | Sentence | denotes | In this case-control study, KIR and HLA genes were genotyped in 400 RA patients and 372 matched healthy controls using sequence-specific primers (SSP-PCR). |
| T10 | 942-1022 | Sentence | denotes | Differences in the frequency of genes and haplotypes were determined by χ² test. |
| T11 | 1023-1122 | Sentence | denotes | RESULTS: KIR2DL2, 2DL5a, 2DL5b and activating KIR: KIR2DS5 and 3DS1 were all protective against RA. |
| T12 | 1123-1266 | Sentence | denotes | KIR2DL5 removal from a full Inhibitory KIR haplotype converted the mild protection (OR = 0.56) to a powerful predisposition to RA (OR = 16.47). |
| T13 | 1267-1291 | Sentence | denotes | Inhibitory haplotype No. |
| T14 | 1292-1398 | Sentence | denotes | 7 comprising KIR2DL5 in the absence of KIR2DL1 and KIR2DL3 confers a 14-fold protective effect against RA. |
| T15 | 1399-1410 | Sentence | denotes | CONCLUSION: |
| T16 | 1411-1464 | Sentence | denotes | Individuals carrying the inhibitory KIR haplotype No. |
| T17 | 1465-1512 | Sentence | denotes | 6 have a high potential risk for developing RA. |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 26658904-2#25#29#gene940 | 302-306 | gene940 | denotes | CD28 |
| 26658904-0#15#56#gene3806 | 15-56 | gene3806 | denotes | Killer Cell Immunoglobulin- Like Receptor |
| 26658904-0#15#56#gene3812 | 15-56 | gene3812 | denotes | Killer Cell Immunoglobulin- Like Receptor |
| 26658904-0#88#108#diseaseC0003873 | 88-108 | diseaseC0003873 | denotes | Rheumatoid Arthritis |
| 26658904-10#13#20#gene57292 | 1305-1312 | gene57292 | denotes | KIR2DL5 |
| 26658904-10#13#20#gene553128 | 1305-1312 | gene553128 | denotes | KIR2DL5 |
| 26658904-10#39#46#gene3802 | 1331-1338 | gene3802 | denotes | KIR2DL1 |
| 26658904-10#51#58#gene3804 | 1343-1350 | gene3804 | denotes | KIR2DL3 |
| 26658904-10#103#105#diseaseC0003873 | 1395-1397 | diseaseC0003873 | denotes | RA |
| 26658904-10#103#105#diseaseC0003873 | 1395-1397 | diseaseC0003873 | denotes | RA |
| 26658904-2#76#78#diseaseC0003873 | 353-355 | diseaseC0003873 | denotes | RA |
| 26658904-8#0#7#gene3803 | 1032-1039 | gene3803 | denotes | KIR2DL2 |
| 26658904-8#42#49#gene3810 | 1074-1081 | gene3810 | denotes | KIR2DS5 |
| 26658904-8#87#89#diseaseC0003873 | 1119-1121 | diseaseC0003873 | denotes | RA |
| 15#56#gene380688#108#diseaseC0003873 | 26658904-0#15#56#gene3806 | 26658904-0#88#108#diseaseC0003873 | associated_with | Killer Cell Immunoglobulin- Like Receptor,Rheumatoid Arthritis |
| 15#56#gene381288#108#diseaseC0003873 | 26658904-0#15#56#gene3812 | 26658904-0#88#108#diseaseC0003873 | associated_with | Killer Cell Immunoglobulin- Like Receptor,Rheumatoid Arthritis |
| 13#20#gene57292103#105#diseaseC0003873 | 26658904-10#13#20#gene57292 | 26658904-10#103#105#diseaseC0003873 | associated_with | KIR2DL5,RA |
| 13#20#gene57292103#105#diseaseC0003873 | 26658904-10#13#20#gene57292 | 26658904-10#103#105#diseaseC0003873 | associated_with | KIR2DL5,RA |
| 13#20#gene553128103#105#diseaseC0003873 | 26658904-10#13#20#gene553128 | 26658904-10#103#105#diseaseC0003873 | associated_with | KIR2DL5,RA |
| 13#20#gene553128103#105#diseaseC0003873 | 26658904-10#13#20#gene553128 | 26658904-10#103#105#diseaseC0003873 | associated_with | KIR2DL5,RA |
| 39#46#gene3802103#105#diseaseC0003873 | 26658904-10#39#46#gene3802 | 26658904-10#103#105#diseaseC0003873 | associated_with | KIR2DL1,RA |
| 39#46#gene3802103#105#diseaseC0003873 | 26658904-10#39#46#gene3802 | 26658904-10#103#105#diseaseC0003873 | associated_with | KIR2DL1,RA |
| 51#58#gene3804103#105#diseaseC0003873 | 26658904-10#51#58#gene3804 | 26658904-10#103#105#diseaseC0003873 | associated_with | KIR2DL3,RA |
| 51#58#gene3804103#105#diseaseC0003873 | 26658904-10#51#58#gene3804 | 26658904-10#103#105#diseaseC0003873 | associated_with | KIR2DL3,RA |
| 25#29#gene94076#78#diseaseC0003873 | 26658904-2#25#29#gene940 | 26658904-2#76#78#diseaseC0003873 | associated_with | CD28,RA |
| 0#7#gene380387#89#diseaseC0003873 | 26658904-8#0#7#gene3803 | 26658904-8#87#89#diseaseC0003873 | associated_with | KIR2DL2,RA |
| 42#49#gene381087#89#diseaseC0003873 | 26658904-8#42#49#gene3810 | 26658904-8#87#89#diseaseC0003873 | associated_with | KIR2DS5,RA |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T978 | 1305-1312 | gene:57292 | denotes | KIR2DL5 |
| T979 | 1395-1397 | disease:C0003873 | denotes | RA |
| R1 | T978 | T979 | associated_with | KIR2DL5,RA |
| R2 | T978 | T979 | associated_with | KIR2DL5,RA |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-109 | Sentence | denotes | Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis. |
| TextSentencer_T2 | 110-121 | Sentence | denotes | OBJECTIVES: |
| TextSentencer_T3 | 122-276 | Sentence | denotes | Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by persistent synovitis, ultimately leading to cartilage and bone degeneration. |
| TextSentencer_T4 | 277-369 | Sentence | denotes | Natural Killer cells and CD28 null T-cells are suspected as role players in RA pathogenesis. |
| TextSentencer_T5 | 370-531 | Sentence | denotes | These cells are similar in feature and function, as they both exert their cytotoxic effect via Killer Cell Immunoglobulin- Like Receptors (KIR) on their surface. |
| TextSentencer_T6 | 532-635 | Sentence | denotes | KIR genes have either an inhibitory or activating effect depending on their intracytoplasmic structure. |
| TextSentencer_T7 | 636-776 | Sentence | denotes | Herein we genotyped 16 KIR genes, 3 pseudo genes and 6 HLA class І genes as their corresponding ligands in RA patients and control subjects. |
| TextSentencer_T8 | 777-785 | Sentence | denotes | METHODS: |
| TextSentencer_T9 | 786-941 | Sentence | denotes | In this case-control study, KIR and HLA genes were genotyped in 400 RA patients and 372 matched healthy controls using sequence-specific primers (SSP-PCR). |
| TextSentencer_T10 | 942-1022 | Sentence | denotes | Differences in the frequency of genes and haplotypes were determined by χ² test. |
| TextSentencer_T11 | 1023-1122 | Sentence | denotes | RESULTS: KIR2DL2, 2DL5a, 2DL5b and activating KIR: KIR2DS5 and 3DS1 were all protective against RA. |
| TextSentencer_T12 | 1123-1266 | Sentence | denotes | KIR2DL5 removal from a full Inhibitory KIR haplotype converted the mild protection (OR = 0.56) to a powerful predisposition to RA (OR = 16.47). |
| TextSentencer_T13 | 1267-1291 | Sentence | denotes | Inhibitory haplotype No. |
| TextSentencer_T14 | 1292-1398 | Sentence | denotes | 7 comprising KIR2DL5 in the absence of KIR2DL1 and KIR2DL3 confers a 14-fold protective effect against RA. |
| TextSentencer_T15 | 1399-1410 | Sentence | denotes | CONCLUSION: |
| TextSentencer_T16 | 1411-1464 | Sentence | denotes | Individuals carrying the inhibitory KIR haplotype No. |
| TextSentencer_T17 | 1465-1512 | Sentence | denotes | 6 have a high potential risk for developing RA. |
| T1 | 0-109 | Sentence | denotes | Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis. |
| T2 | 110-121 | Sentence | denotes | OBJECTIVES: |
| T3 | 122-276 | Sentence | denotes | Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by persistent synovitis, ultimately leading to cartilage and bone degeneration. |
| T4 | 277-369 | Sentence | denotes | Natural Killer cells and CD28 null T-cells are suspected as role players in RA pathogenesis. |
| T5 | 370-531 | Sentence | denotes | These cells are similar in feature and function, as they both exert their cytotoxic effect via Killer Cell Immunoglobulin- Like Receptors (KIR) on their surface. |
| T6 | 532-635 | Sentence | denotes | KIR genes have either an inhibitory or activating effect depending on their intracytoplasmic structure. |
| T7 | 636-776 | Sentence | denotes | Herein we genotyped 16 KIR genes, 3 pseudo genes and 6 HLA class І genes as their corresponding ligands in RA patients and control subjects. |
| T8 | 777-785 | Sentence | denotes | METHODS: |
| T9 | 786-941 | Sentence | denotes | In this case-control study, KIR and HLA genes were genotyped in 400 RA patients and 372 matched healthy controls using sequence-specific primers (SSP-PCR). |
| T10 | 942-1022 | Sentence | denotes | Differences in the frequency of genes and haplotypes were determined by χ² test. |
| T11 | 1023-1122 | Sentence | denotes | RESULTS: KIR2DL2, 2DL5a, 2DL5b and activating KIR: KIR2DS5 and 3DS1 were all protective against RA. |
| T12 | 1123-1266 | Sentence | denotes | KIR2DL5 removal from a full Inhibitory KIR haplotype converted the mild protection (OR = 0.56) to a powerful predisposition to RA (OR = 16.47). |
| T13 | 1267-1291 | Sentence | denotes | Inhibitory haplotype No. |
| T14 | 1292-1398 | Sentence | denotes | 7 comprising KIR2DL5 in the absence of KIR2DL1 and KIR2DL3 confers a 14-fold protective effect against RA. |
| T15 | 1399-1410 | Sentence | denotes | CONCLUSION: |
| T16 | 1411-1464 | Sentence | denotes | Individuals carrying the inhibitory KIR haplotype No. |
| T17 | 1465-1512 | Sentence | denotes | 6 have a high potential risk for developing RA. |